首頁 › 肥胖症 › 印第安納 › Indianapolis
Indianapolis, IN 的 肥胖症 臨床試驗
20 項針對 肥胖症 的研究正在 Indianapolis（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
招募中3 期
- IU Health - Riley Physicians Endo-Diab, Indianapolis
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
招募中2 期
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
招募中3 期
- Midwest Inst For Clin Res, Indianapolis
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
招募中3 期
- Midwest Inst For Clin Res, Indianapolis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Indiana University Health University Hospital, Indianapolis
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
招募中3 期
- Riley Hospital for Children, Indianapolis
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
招募中3 期
- Midwest Inst For Clin Res, Indianapolis
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
招募中3 期
- Indiana University Health University Hospital, Indianapolis
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- DM Clinical Research - Indianapolis, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Indianapolis
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
招募中3 期
- Ascension Medical Group, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Indianapolis
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
招募中2 期
- Investigators Research Group, Brownsburg · 距離 14 英里
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
招募中4 期
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
- The Indiana Clinical Trials Center, PC, Plainfield · 距離 14 英里
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
招募中3 期
- Midwest Inst For Clin Res, Indianapolis
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
招募中2 期
- Indiana University School of Medicine, Indianapolis
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
招募中3 期
- Indiana University Health Methodist Hospital, Indianapolis
A Sensory Strategy to Cut Sugary Beverages in African/American and Latine Adolescents
招募中歡迎健康志工
- Indiana University Hospital, Indianapolis
Fibrosis Lessens After Metabolic Surgery
招募中4 期歡迎健康志工
- Indiana University, Indianapolis
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
招募中
- Indiana University, Indianapolis
其他城市的 肥胖症 試驗
- Houston, TX43 項研究
- Chicago, IL41 項研究
- New York City, NY40 項研究
- San Antonio, TX40 項研究
- Washington, DC33 項研究
- Orlando, FL32 項研究
- Dallas, TX30 項研究
- Boston, MA28 項研究
- Las Vegas, NV27 項研究
- Miami, FL27 項研究
- Baltimore, MD26 項研究
- Jacksonville, FL25 項研究
Indianapolis 的其他研究
- 非小細胞肺癌32 項研究
- 癌症（所有類型）24 項研究
- 心臟衰竭23 項研究
- 乳癌20 項研究
- 轉移性癌症19 項研究
- 大腸直腸癌18 項研究
- 卵巢癌17 項研究
- 心血管疾病17 項研究
- 肺癌16 項研究
- 第一型糖尿病14 項研究
- 子宮內膜癌14 項研究
- 阿茲海默症14 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。